Showing 22,152 results

Filters Content type: Editors' picks
Pharmaceutical industry

Thailand’s switch to dolutegravir: more generic versions needed!

Editor's pick
Medicines Patent Pool
31 October 2021
Government, leadership & policy

How to end the AIDS epidemic in western and central Africa

Editor's pick
UNAIDS
31 October 2021
Government, leadership & policy

Amid Multiple Crises, Haiti's Efforts Against HIV Continue as Best They Can

Editor's pick
TheBody
31 October 2021
People who inject drugs

US: White People Who Inject Drugs Took More Risks, but More Black People Got HIV

Editor's pick
POZ
31 October 2021
Government, leadership & policy

Five questions about the HIV response in Nigeria

Editor's pick
UNAIDS
31 October 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces European Commission Decision for Vocabria (cabotegravir) and Rekambys (rilpivirine) injections to be initiated with or without an oral lead-in period for the long-acting treatment of HIV

Editor's pick
ViiV Healthcare
28 October 2021
Low & theoretical transmission risks

Fact Check - Transmission of HIV by needle injuries is highly unlikely, according to a British AIDS charity

Editor's pick
Reuters
27 October 2021
Bad science & bogus treatments

Facebook, YouTube Take Down Bolsonaro Video That Said Vaccines Cause AIDS

Editor's pick
The Wire
26 October 2021
Injectable & long-acting HIV treatment

Gilead and Merck Initiate Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Lenacapavir and Investigational Islatravir for HIV-1 Treatment in Virologically Suppressed Adults

Editor's pick
Gilead press release
26 October 2021
Access to healthcare

New study confirms MPP licences save money and lives

Editor's pick
Medicines Patent Pool
26 October 2021
Sexually transmitted infections epidemiology

Should we be worried about donovanosis, a rare, so-called 'flesh-eating' STI?

Editor's pick
The Washington Post
26 October 2021
Travel

UNAIDS welcomes New Zealand’s decision to lift travel restrictions for people living with HIV

Editor's pick
UNAIDS
25 October 2021
New & experimental HIV treatments

Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1 Infection

Editor's pick
Merck press release
25 October 2021
Confidentiality, consent & medical ethics

HIV Scotland fined £10,000 for email data breach

Editor's pick
BBC News
25 October 2021
Coronavirus

Namibia Halts Use of Russian Sputnik Jabs After S.African HIV Fears

Editor's pick
The Moscow Times
25 October 2021
HIV testing policies & guidelines

Opt-out HIV testing is best for Black African populations in the UK

Editor's pick
Terrence Higgins Trust
25 October 2021
Mental & emotional health problems

UK: Mental health services are failing to support people living with HIV, new report finds

Editor's pick
National AIDS Trust
24 October 2021
HIV & criminal law

Mumbai court upholds detention of HIV+ sex worker, rules 'setting her free poses danger to society’

Editor's pick
The Free Press Journal
24 October 2021
HIV & criminal law

Molecular HIV Surveillance: A Global Review of Human Rights Implications

Editor's pick
HIV Justice Worldwide
24 October 2021
HIV & criminal law

What to Know About California’s Law Banning Non-Consensual Condom Removal

Editor's pick
TheBody
24 October 2021
Travel

New Zealand: Major hurdle for HIV-positive immigrants to be removed

Editor's pick
Stuff
22 October 2021
PrEP policies & guidelines

Gilead Announces Decision Not to Pursue Marketing Authorization for Descovy® for Pre-Exposure Prophylaxis in the European Union

Editor's pick
Gilead press release
22 October 2021
Coronavirus

The verdict is in — and Sputnik V is out

Editor's pick
Bhekisisa
21 October 2021
Behaviour change interventions

UN-backed show highlights lifesaving benefits of 'edutainment' in South Africa

Editor's pick
UN News
21 October 2021